Literature DB >> 33597011

Human fetal liver MSCs are more effective than adult bone marrow MSCs for their immunosuppressive, immunomodulatory, and Foxp3+ T reg induction capacity.

Sina Naserian1,2,3, Estelle Oberlin4,5, Yi Yu6,7,8, Alejandra Vargas Valderrama7,9, Zhongchao Han6,8, Georges Uzan7,9.   

Abstract

BACKGROUND: Mesenchymal stem cells (MSCs) exhibit active abilities to suppress or modulate deleterious immune responses by various molecular mechanisms. These cells are the subject of major translational efforts as cellular therapies for immune-related diseases and transplantations. Plenty of preclinical studies and clinical trials employing MSCs have shown promising safety and efficacy outcomes and also shed light on the modifications in the frequency and function of regulatory T cells (T regs). Nevertheless, the mechanisms underlying these observations are not well known. Direct cell contact, soluble factor production, and turning antigen-presenting cells into tolerogenic phenotypes, have been proposed to be among possible mechanisms by which MSCs produce an immunomodulatory environment for T reg expansion and activity. We and others demonstrated that adult bone marrow (BM)-MSCs suppress adaptive immune responses directly by inhibiting the proliferation of CD4+ helper and CD8+ cytotoxic T cells but also indirectly through the induction of T regs. In parallel, we demonstrated that fetal liver (FL)-MSCs demonstrates much longer-lasting immunomodulatory properties compared to BM-MSCs, by inhibiting directly the proliferation and activation of CD4+ and CD8+ T cells. Therefore, we investigated if FL-MSCs exert their strong immunosuppressive effect also indirectly through induction of T regs.
METHODS: MSCs were obtained from FL and adult BM and characterized according to their surface antigen expression, their multilineage differentiation, and their proliferation potential. Using different in vitro combinations, we performed co-cultures of FL- or BM-MSCs and murine CD3+CD25-T cells to investigate immunosuppressive effects of MSCs on T cells and to quantify their capacity to induce functional T regs.
RESULTS: We demonstrated that although both types of MSC display similar cell surface phenotypic profile and differentiation capacity, FL-MSCs have significantly higher proliferative capacity and ability to suppress both CD4+ and CD8+ murine T cell proliferation and to modulate them towards less active phenotypes than adult BM-MSCs. Moreover, their substantial suppressive effect was associated with an outstanding increase of functional CD4+CD25+Foxp3+ T regs compared to BM-MSCs.
CONCLUSIONS: These results highlight the immunosuppressive activity of FL-MSCs on T cells and show for the first time that one of the main immunoregulatory mechanisms of FL-MSCs passes through active and functional T reg induction.

Entities:  

Keywords:  Adult bone marrow; Fetal liver; Induced regulatory T cells; Mesenchymal stem cells; T cell immunomodulation

Year:  2021        PMID: 33597011      PMCID: PMC7888159          DOI: 10.1186/s13287-021-02176-1

Source DB:  PubMed          Journal:  Stem Cell Res Ther        ISSN: 1757-6512            Impact factor:   6.832


  105 in total

1.  In vitro Treg suppression assays.

Authors:  Lauren W Collison; Dario A A Vignali
Journal:  Methods Mol Biol       Date:  2011

2.  Clonal analysis of multipotent stromal cells derived from CD271+ bone marrow mononuclear cells: functional heterogeneity and different mechanisms of allosuppression.

Authors:  Zyrafete Kuçi; Julia Seiberth; Hatixhe Latifi-Pupovci; Sibylle Wehner; Stefan Stein; Manuel Grez; Halvard Bönig; Ulrike Köhl; Thomas Klingebiel; Peter Bader; Selim Kuçi
Journal:  Haematologica       Date:  2013-08-23       Impact factor: 9.941

3.  IL-17A improves the efficacy of mesenchymal stem cells in ischemic-reperfusion renal injury by increasing Treg percentages by the COX-2/PGE2 pathway.

Authors:  Ming Bai; Li Zhang; Bo Fu; Jiuxu Bai; Yingjie Zhang; Guangyan Cai; Xueyuan Bai; Zhe Feng; Shiren Sun; Xiangmei Chen
Journal:  Kidney Int       Date:  2017-11-11       Impact factor: 10.612

4.  Fetal and adult hematopoietic stem cells give rise to distinct T cell lineages in humans.

Authors:  Jeff E Mold; Shivkumar Venkatasubrahmanyam; Trevor D Burt; Jakob Michaëlsson; Jose M Rivera; Sofiya A Galkina; Kenneth Weinberg; Cheryl A Stoddart; Joseph M McCune
Journal:  Science       Date:  2010-12-17       Impact factor: 47.728

5.  Autologous mesenchymal stromal cells and kidney transplantation: a pilot study of safety and clinical feasibility.

Authors:  Norberto Perico; Federica Casiraghi; Martino Introna; Eliana Gotti; Marta Todeschini; Regiane Aparecida Cavinato; Chiara Capelli; Alessandro Rambaldi; Paola Cassis; Paola Rizzo; Monica Cortinovis; Maddalena Marasà; Josee Golay; Marina Noris; Giuseppe Remuzzi
Journal:  Clin J Am Soc Nephrol       Date:  2010-10-07       Impact factor: 8.237

6.  Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow.

Authors:  C Campagnoli; I A Roberts; S Kumar; P R Bennett; I Bellantuono; N M Fisk
Journal:  Blood       Date:  2001-10-15       Impact factor: 22.113

7.  TNF-α priming enhances CD4+FoxP3+ regulatory T-cell suppressive function in murine GVHD prevention and treatment.

Authors:  Antonio Pierini; William Strober; Caitlin Moffett; Jeanette Baker; Hidekazu Nishikii; Maite Alvarez; Yuqiong Pan; Dominik Schneidawind; Everett Meyer; Robert S Negrin
Journal:  Blood       Date:  2016-06-30       Impact factor: 22.113

Review 8.  Differentiation of Human Mesenchymal Stem Cells towards Neuronal Lineage: Clinical Trials in Nervous System Disorders.

Authors:  Rosa Hernández; Cristina Jiménez-Luna; Jesús Perales-Adán; Gloria Perazzoli; Consolación Melguizo; José Prados
Journal:  Biomol Ther (Seoul)       Date:  2019-10-25       Impact factor: 4.634

9.  Mesenchymal stem cells generate a CD4+CD25+Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cells.

Authors:  Patricia Luz-Crawford; Monica Kurte; Javiera Bravo-Alegría; Rafael Contreras; Estefania Nova-Lamperti; Gautier Tejedor; Danièle Noël; Christian Jorgensen; Fernando Figueroa; Farida Djouad; Flavio Carrión
Journal:  Stem Cell Res Ther       Date:  2013-06-04       Impact factor: 6.832

Review 10.  Mesenchymal stem cells and immunomodulation: current status and future prospects.

Authors:  F Gao; S M Chiu; D A L Motan; Z Zhang; L Chen; H-L Ji; H-F Tse; Q-L Fu; Q Lian
Journal:  Cell Death Dis       Date:  2016-01-21       Impact factor: 8.469

View more
  7 in total

Review 1.  Immunomodulatory effects of mesenchymal stem cells in peripheral nerve injury.

Authors:  Xiangling Li; Yanjun Guan; Chaochao Li; Tieyuan Zhang; Fanqi Meng; Jian Zhang; Junyang Li; Shengfeng Chen; Qi Wang; Yi Wang; Jiang Peng; Jinshu Tang
Journal:  Stem Cell Res Ther       Date:  2022-01-15       Impact factor: 6.832

Review 2.  Current status of clinical trials assessing mesenchymal stem cell therapy for graft versus host disease: a systematic review.

Authors:  Ying Li; Jie Hao; Zheng Hu; Yong-Guang Yang; Qi Zhou; Liguang Sun; Jun Wu
Journal:  Stem Cell Res Ther       Date:  2022-03-04       Impact factor: 6.832

3.  Adipose-derived stem cells alleviate liver injury induced by type 1 diabetes mellitus by inhibiting mitochondrial stress and attenuating inflammation.

Authors:  Yanli Hou; Wenyu Ding; Peishan Wu; Changqing Liu; Lina Ding; Junjun Liu; Xiaolei Wang
Journal:  Stem Cell Res Ther       Date:  2022-04-01       Impact factor: 6.832

Review 4.  An Update on Applications of Cattle Mesenchymal Stromal Cells.

Authors:  Barbara Merlo; Penelope Maria Gugole; Eleonora Iacono
Journal:  Animals (Basel)       Date:  2022-08-02       Impact factor: 3.231

5.  CD1d-independent NK1.1+ Treg cells are IL2-inducible Foxp3+ T cells co-expressing immunosuppressive and cytotoxic molecules.

Authors:  Hyun Jung Park; Sung Won Lee; Yun Hoo Park; Tae-Cheol Kim; Luc Van Kaer; Seokmann Hong
Journal:  Front Immunol       Date:  2022-09-13       Impact factor: 8.786

6.  Liver mesenchymal stem cells are superior inhibitors of NK cell functions through differences in their secretome compared to other mesenchymal stem cells.

Authors:  Furkan Yigitbilek; Elif Ozdogan; Nitin Abrol; Walter D Park; Michael J Hansen; Surendra Dasari; Mark D Stegall; Timucin Taner
Journal:  Front Immunol       Date:  2022-09-21       Impact factor: 8.786

Review 7.  Immunomodulatory Effect of MSCs and MSCs-Derived Extracellular Vesicles in Systemic Lupus Erythematosus.

Authors:  Chunjuan Yang; Jianmei Sun; Yipeng Tian; Haibo Li; Lili Zhang; Jinghan Yang; Jinghua Wang; Jiaojiao Zhang; Shushan Yan; Donghua Xu
Journal:  Front Immunol       Date:  2021-09-16       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.